<DOC>
	<DOCNO>NCT02789605</DOCNO>
	<brief_summary>Recurrent aphthous stomatitis ( RAS ) frequent condition characterize recurrent painful oral ulcer unknown pathophysiology . Recent study suggest dysregulation oral microbiota may implicate . Currently , therapies RAS limit severe side effect inconstant effectiveness . The aim study ass effectiveness safety probiotic , Lactobacillus rhamnosus Lcr35速 , treatment RAS . A placebo-controlled , parallel study conduct 40 subject RAS . Treatment consist administration daily probiotic placebo 3 months.All patient follow additional 3months without treatment . The main outcome measure number occur aphtae .</brief_summary>
	<brief_title>Effectiveness Safety Lactobacillus Rhamnosus Lcr35速 Treatment Recurrent Aphthous Stomatitis</brief_title>
	<detailed_description>Recurrent aphthous stomatitis ( RAS ) common chronic disease oral cavity , affect 5-25 % population . This condition characterize recurrent painful oral ulcer . The discomfort RAS impact negatively quality life therapeutic demand strong . Currently , curative treatment RAS , suspensive treatment colchicine thalidomide definitive induce severe side effect . The pathophysiology RAS remain largely unknown . Recent study suggest dysregulation oral microbiota may implicate . Increasing data underline potential interest use probiotic condition due microbiota disorder . To best knowledge , study evaluate effectiveness probiotic RAS . The main objective double blind clinical trial evaluate effectiveness safety probiotic , Lactobacillus rhamnosus Lcr35速 , treatment RAS adult . 40 patient suffer minor RAS 6 month include randomly assign 2 group 20 . Patients group A take Lactobacillus rhamnosus Lcr35速 orally daily 3 month patient group B take placebo similarly . All patient follow 3 additional month without treatment . The primary outcome measure monthly number aphthae occur 3 month treatment . The secondary outcome measure monthly number aphthae occur 3 month follow , pain reduction , impact quality life accord OHIP-14 score side effect .</detailed_description>
	<mesh_term>Stomatitis</mesh_term>
	<mesh_term>Stomatitis , Aphthous</mesh_term>
	<criteria>18 yearold Recurrent idiopathic aphtous stomatitis least one new lesion per month past 6 month . Symptomatic aphtosis associate Crohn Behcet disease Concomitant use probiotic reason Systemic use colchicine steroid immunosuppressive drug past 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Aphthous Stomatitis [ C07.465.864.750 ]</keyword>
</DOC>